Graft-Versus-Host Disease

University of Minnesota
Completed Trials
  • Researchers studied biomarkers of patients prior to Hematopoietic Cell Transplantation (HCT). Compared to 16 healthy control patients, "pre-transplant patients came to transplant with abnormal levels of all three biomarkers, reflecting residual damage from prior chemotherapy." The study suggests that pre-HCT interventions to the gut microbiome may decrease patient risk for Graft-Versus-Host disease post HCT. Read the study publication here.
  • Hear more about Graft versus Host disease from Dr. Shernan Holtan, researcher at the University of Minnesota.